37
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Chronic Myeloid Leukemia in a Woman with Papillary Carcinoma of the Thyroid Treated with Radioactive Iodine

, &
Pages 365-367 | Accepted 30 Nov 1996, Published online: 01 Jul 2009

References

  • Blom P.S., Querido A., Leeksma C.H.W. Acute leukemia following X-ray and radioiodine treatment of thyroid carcinoma. Br J Radiol 1955; 28: 165–166
  • Seidlin S.M., Seigel E., Melamad S., Yallow A.A. Occurrence of myeloid leukemia in patients with metastatic thyroid carcinoma following prolonged massive radioiodine therapy. Bull NY Acad Med 1955; 31: 410
  • Pochin E.E. Leukaemia following radioiodine treatment of thyrotoxicosis. Br Med J 1960; 2: 1545–1550
  • Ozarda A., Ergin U., Bender M.A. Chronic myelogenous leukemia following I131 therapy for metastatic thyroid carcinoma. Am J Roentgeology, Radium Ther, Nuc Med 1961; 85: 914–918
  • Pochin E.E. Prospects from the treatment of thyroid carcinoma with radioiodine. Clin Radiol 1967; 18: 113–115
  • Brincker H., Hansen H.S., Anderson A.P. Induction of leukaemia by radioiodine treatment of thyroid carcinoma. Br J Cancer 1973; 28: 232–237
  • Bundi R.S., Scott J.S., Hainan K.E. Chronic myeloid leukaemia following radioiodine therapy for carcinoma of the thyroid. Br J Radiol 1977; 50: 61–64
  • Walgraeve D., Verhoef G., Stul M. Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma. Cancer Genet Cytogenet 1991; 55: 217–224
  • Advani S.H., Hege U.P. Leukemia after 131I treatment of thyroid cancer-comments on the article “Second cancer following chemotherapy and radioiodine-an epidemiological perspective” by J Kaldor. Acta Oncol 1992; 31: 65
  • Goldman M.B., Monson R.R., Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 1990; 50: 2283–2289
  • Hoffman D.A., McConahey W.M., Fraumeni J.F., Kurland L.T. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol 1982; 11: 218–224
  • Saenger E.L., Thoma G.E., Tompkins E.A. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report for the cooperative Thyrotoxicosis Therapy Follow-Up Study. JAMA 1968; 205: 855–62
  • Edmonds C.J., Smith T. The long-term hazards of treatment of thyroid cancer with radioiodine. Br J Radiol 1986; 59: 45–51
  • Hall P., Holm L.-E., Lundell G. Cancer risks in thyroid cancer patients. Br J Cancer 1991; 64: 159–163
  • Holm L.-E., Hall P., Wiklund K. Cancer risk after iodine-131 therapy for hyperthyroidism. JNCI 1991; 83: 1072–1077
  • Hall P., Berg G., Bjelkengren G. Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer 1992; 50: 886–890
  • Hall P., Boice J.D., Berg G. Leukaemia incidence after iodine-131 exposure. Lancet 1992; 340: 1.4
  • Britton R., Sachmechi I., Benegalrao Y., Schneider B.S. Leukemia after a small dose of radioiodine for metastatic thyroid cancer. J Clin Endocrinol Metab 1993; 77: 1423–6
  • Stavem P., Van der Hagen C.B., Vogt E., Surdnes K. Polycythemia vera treated with 32P and myleran: development of abnormalities in one patient. Clin Genet 1975; 7: 227–31
  • Lipton J.H., Messner H.A. Chronic myeloid leukemia in a woman with Still's disease treated with 198Au synoviorthesis. J Rheumatol 1991; 18: 745–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.